BEVACIZUMAB
Clinical trials for BEVACIZUMAB explained in plain language.
Never miss a new study
Get alerted when new BEVACIZUMAB trials appear
Sign up with your email to follow new studies for BEVACIZUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New brain radiation combo aims to control tumors and save memory
Disease control Recruiting nowThis study tests two ways to treat lung cancer that has spread to the brain. One group gets focused radiation plus a drug called bevacizumab; the other gets whole-brain radiation that tries to protect the memory center. The goal is to see which approach better controls the brain …
Matched conditions: BEVACIZUMAB
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New Triple-Threat attack on tough liver cancer
Disease control Recruiting nowThis study is testing a three-part treatment for advanced liver cancer that has spread into a major vein in the liver. The treatment combines immunotherapy (QL1706), a drug that blocks tumor blood supply (bevacizumab), and chemotherapy delivered directly into the liver's artery. …
Matched conditions: BEVACIZUMAB
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Apr 13, 2026 20:18 UTC